LINC00903

Across TCGA pan-cancer cohorts, LINC00903 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC00903 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LINC00903 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00903 expression acts as an unfavorable survival marker, although some lineages such as ACC show a favorable association.

LUSC, READ, and STAD are the cancer types where LINC00903 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.186	0.663	.009	63	view →
READ	DFS	Tertile	All	0.150	0.566	.009	45	view →
STAD	OS	Tertile	II,III,IV	0.469	0.685	.015	39	view →
KIRC	DFS	Tertile	All	0.118	0.627	.009	18	view →
HNSC	OS	Tertile	All	0.191	0.710	.021	18	view →
UCEC	DFS	Tertile	All	0.370	0.652	.023	12	view →
BLCA	OS	Tertile	III,IV	0.175	0.579	.028	9	view →
KIRP	DFS	Tertile	All	0.277	0.867	.004	9	view →
ACC	OS	Tertile	IV	1.000	0.530	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC00903–LUSC (DFS)

Open the LUSC breakdown →